Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
CAMBRIDGE, Mass., April 22, 2024 -- Generation Bio Co. a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts...
Source: marketscreener.com